Skip to main content

Table 1 (abstract P320). please see text description

From: 38th International Symposium on Intensive Care and Emergency Medicine

 

Intervention [TAK-954 0.5 mg; n = 7] n (%)

Control [n = 6; metoclopramide 10 mg] n (%)

Total number of AEs

8

5

Patients reporting at least 1 AEa

5 (71.4)

4 (66.7)

Any moderate or severe AEs

3 (42.9)b

3 (50.0)c

Any serious AEsd

2 (28.6)e

3 (50.0)f

AEs leading to discontinuation

0 (0)

0 (0)

Any AEs leading to drug interruption

0 (0)

0 (0)

Deaths

2 (28.6)

3 (50.0)

  1. aOnly one AE (diarrhea in the metoclopramide group) was considered to be potentially treatment-related
  2. bOne patient reported each of the following: cerebral hemorrhage, respiratory failure and decubitus ulcer
  3. cOne patient reported each of the following: hemmorhage intracranial, subarachnoid hemmorhage, disease progression, hypertension
  4. dNo serious AEs (including deaths) were considered to be treatment-related in either group
  5. eOne patient reported each of the following: cerebral hemorrhage and respiratory failure
  6. fOne patient reported each of the following: hemmorhage intracranial, subarachnoid haemorrhage and disease progression AE, adverse event
Back to article page

Critical Care

ISSN: 1364-8535